Concepedia

Antony Letai

AL

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2007

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Massachusetts General Hospital

Broad Institute

Antony Letai is an author at Harvard University specializing in medicine, cell biology, and cell death.

Top concepts

Publications per year

2007–2017

11

Publications

11

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shaokun Shu, Charles Y. Lin, Housheng Hansen He et al. · Nature · 2016 · 616 citations · Full text

, , +9

Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes

Andriy Marusyk, Doris P. Tabassum, Michalina Janiszewska et al. · Cancer Research · 2016 · 139 citations · Full text

Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells

Selçuk Çolak, Cheryl Zimberlin, Evelyn Fessler et al. · Cell Death and Differentiation · 2014 · 113 citations · Full text

, , +8

Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma

Jianjun Zhao, Zhang-Bo Chu, Jianhong Lin et al. · Cancer Research · 2015 · 88 citations · Full text

, , +12

Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells

Özgür Kütük, Antony Letai · Cell Death and Differentiation · 2010 · 87 citations · Full text

, , +11

1–5 of 11